Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vodobatinib (K-0706) is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity.
説明 | Vodobatinib (K-0706) is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity. |
ターゲット&IC50 | BCR-ABL1:7 nM (IC50) |
別名 | K-0706 |
分子量 | 453.92 |
分子式 | C27H20ClN3O2 |
CAS No. | 1388803-90-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (55.07 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vodobatinib 1388803-90-4 Angiogenesis Cytoskeletal Signaling Tyrosine Kinase/Adaptors Bcr-Abl myeloid Inhibitor inhibit K 0706 K-0706 chronic Bcr-Abl1 K0706 leukemia TKI inhibitor